Salim Dhanji
Chief Executive Officer at ME THERAPEUTICS HOLDINGS INC.
Net worth: 21 M $ as of 2024-05-30
Salim Dhanji active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Director/Board Member | 2023-03-08 | - |
| Chief Executive Officer | 2023-03-08 | - |
Career history of Salim Dhanji
Former positions of Salim Dhanji
| Companies | Position | Start | End |
|---|---|---|---|
Qu Biologics, Inc.
 Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Corporate Officer/Principal | 2008-12-31 | 2013-12-31 |
Training of Salim Dhanji
| University of British Columbia | Doctorate Degree |
Statistics
International
| Canada | 4 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Stock Market
- Insiders
- Salim Dhanji
- Experience
